<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral <z:mp ids='MP_0005039'>hypoxia</z:mp> may be the main component of cell damage caused by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Previous studies demonstrated a neuroprotective effect of early hyperbaric oxygen (HBO) treatment in various animal models of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Neuropathologic study showed that exposure of HBO may prevent cell <z:hpo ids='HP_0011420'>death</z:hpo> in ischemic cortex </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, we aimed to assess cellular function of ischemic rat brain after HBO treatment by means of a high-resolution <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography scanner (microPET) used specifically for small animal imaging </plain></SENT>
<SENT sid="4" pm="."><plain>The male Sprague-Dawley rats were subjected to permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), with the regional cerebral blood flow monitored in vivo by laser Doppler flowmetry </plain></SENT>
<SENT sid="5" pm="."><plain>One hour after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, HBO therapy (3 atm absolute, 1 h) was initiated </plain></SENT>
<SENT sid="6" pm="."><plain>Local cerebral <z:chebi fb="105" ids="17234">glucose</z:chebi> utilization in the ischemic area was measured before, 1 h and 3 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, with 2-[(18)F]-fluoro-2-deoxy-d-<z:chebi fb="105" ids="17234">glucose</z:chebi> (FDG) as a tracer </plain></SENT>
<SENT sid="7" pm="."><plain>Neurological deficits and <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were assessed at 24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Our study showed that early HBO therapy significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume of brain 24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, <z:chebi fb="105" ids="17234">glucose</z:chebi> utilization in the ischemic area underwent a severe decrease during 1-3 h after MCAO, while the early HBO treatment significantly attenuated the decrease in cerebral metabolic rate of <z:chebi fb="105" ids="17234">glucose</z:chebi> in the ischemic core of the cortex compared with controls </plain></SENT>
<SENT sid="10" pm="."><plain>We report for the first time the application of microPET to quantify the rates of <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism in the ischemic core of rats exposed to HBO </plain></SENT>
<SENT sid="11" pm="."><plain>Our results suggest that the early exposure of HBO can partially reverse the downward trend for <z:chebi fb="105" ids="17234">glucose</z:chebi> utilization in the ischemic core, which might contribute to the reported beneficial effects of early HBO therapy on permanent <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>